Donate Help Contact The AHA Sign In Home
American Heart Association
Stroke
Search: search_blue_button Advanced Search
Stroke. 1986;17:1004-1009

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Scremin, O. U.
Right arrow Articles by Scremin, A. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Scremin, O. U.
Right arrow Articles by Scremin, A. M.

Stroke, Vol 17, 1004-1009, Copyright © 1986 by American Heart Association


ARTICLES

Physostigmine induced reversal of ischemia following acute middle cerebral artery occlusion in the rat

OU Scremin and AM Scremin

Cerebral cortical ischemia was induced in anesthetized rats by occlusion of the middle cerebral artery (MCA). Cerebral blood flow (CBF) was measured with the H2 clearance technique in the center and periphery of the ischemic territory. A decrease of CBF to about 50% of pre-occlusion values was observed in both areas. Administration of Physostigmine, a cholinesterase inhibitor, at a dose of 0.15 mg/Kg by intravenous route, induced an increase of CBF in the ischemic cortex. This change in CBF reached 120% of pre-occlusion level in the periphery and 80% of pre-occlusion value in the center of the area of distribution of the occluded artery. Although Physostigmine induced an increase in arterial blood pressure, the cerebral hyperemia observed both in normal and ischemic cortex could still be demonstrated after blockade of the pressor effect by bleeding or Phentolamine administration.


This article has been cited by other articles:


Home page
J. Pharmacol. Exp. Ther.Home page
Y. Nakada, O. Yokoyama, K. Komatsu, K. Kodama, S. Yotsuyanagi, S. Niikura, Y. Nagasaka, and M. Namiki
Effects of Aniracetam on Bladder Overactivity in Rats with Cerebral Infarction
J. Pharmacol. Exp. Ther., June 1, 2000; 293(3): 921 - 928.
[Abstract] [Full Text]